Skip to content

Clinical trials

Neurodegenerative Diseases trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neurodegenerative Diseases Country / region: Germany Clear all

48 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20092
20102
20113
20121
20133
20142
20165
20173
20184
20192
20205
20211
20223
20235
20243
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21
Terminated9
Recruiting6
Unknown status6
Active, not recruiting5
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie4
GenSight Biologics3
Novartis Pharmaceuticals3
TauRx Therapeutics Ltd3
AstraZeneca2
Ludwig-Maximilians - University of Munich2
Technische Universität Dresden2
University Hospital Tuebingen2
Vertex Pharmaceuticals Incorporated2
AO Innovation Translation Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neurodegenerative Diseases48
Nervous System Diseases20
Brain Diseases19
Central Nervous System Diseases16
Dementia15
Parkinson Disease15
Alzheimer Disease13
Movement Disorders9
Mental Disorders8
Parkinsonian Disorders8

Trials

Showing 76 to 48 of 48. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.